Dr. Milana Frenkel-Morgenstern's group at the Azrieli Faculty of Medicine, Bar-Ilan University aims to identify unique potential drug targets in cancer cells, also known as “chimeric RNAs”. Her group catalogs these cancer-associated fusion transcripts, thereby analyzing the function of the proteins produced by the transcripts in order to identify those fusion events that are directly related to biochemical cell function.
Dr. Alessandro Gorohovski Collaborator in Computational Biology The Azrieli Faculty of Medicine, Bar-Ilan University, Israel
Rajesh Detroja Ph. D. Student, The Azrieli Faculty of Medicine, Bar-Ilan University, Israel
Vikrant Palande Ph. D. Student, The Azrieli Faculty of Medicine, Bar-Ilan University, Israel
Dr. Dorith Raviv Shay The Azrieli Faculty of Medicine, Bar-Ilan University, Israel
Prof. Alfonso Valencia's group is dedicated to the application of machine learning and artificial intelligence to Personalized Medicine, and exhibits ample experience in the development of software platforms for the extraction, integration and representation of big data for large-scale genome projects.Prof. Asa Ben-Hur The department of Computer Sciences The Colorado State University, USA Prof. Jaime Prilusky Head of Bioinformatics R&D Bioinformatics and Data Management Weizmann Institute of Science, Rehovot, Israel Prof. Roderic Guigo Genome Informatics Research Laboratory Center Genomic Regulation, Barcelona, Spain Dr. Vincent Lacroix Baobab Group, The Biometry and Evolutionary Biology laboratory UCBL, Lyon, France Dr. Yishai Levin Head of the de Botton Institute for Protein Profiling Israel National for Personalised Medicine, Weizmann Institute of Science, Rehovot, Israel